XBiotech Balance Sheet Health
Financial Health criteria checks 3/6
XBiotech has a total shareholder equity of $196.7M and total debt of $10.0M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are $215.6M and $18.9M respectively.
Key information
5.1%
Debt to equity ratio
US$10.00m
Debt
| Interest coverage ratio | n/a |
| Cash | US$188.53m |
| Equity | US$196.70m |
| Total liabilities | US$18.85m |
| Total assets | US$215.56m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4XB's short term assets ($190.6M) exceed its short term liabilities ($17.1M).
Long Term Liabilities: 4XB's short term assets ($190.6M) exceed its long term liabilities ($1.7M).
Debt to Equity History and Analysis
Debt Level: 4XB has more cash than its total debt.
Reducing Debt: 4XB's debt to equity ratio has increased from 0% to 5.1% over the past 5 years.
Debt Coverage: 4XB's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 4XB's interest payments on its debt are well covered by EBIT.